← Leaderboards
Fadi Gabriel Akar
Johns Hopkins University
$9,503,044
Attributed
$15,714,661
Total exposure
12
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,714,661 · 12
By mechanism
R01$13,873,643 · 8
R21$1,841,018 · 4
Top collaborators
- Miguel Antonio Aon5 shared
- Nazareno Paolocci5 shared
- Roger J. Hajjar4 shared
- Brian O'Rourke4 shared
- Lawrence H Young4 shared
- Stuart G Campbell3 shared
- Robert A Levine1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Paul F Worley$57,319,879
- Cynthia A James$1,501,188
- Daniel P Judge$1,108,290
Others in their field
Top investigators on “Arrhythmia”
- Dan M Roden · Vanderbilt University Medical Center$63,173,998
- Lynn A Sleeper · New England Research Institutes, Inc.$48,939,627
- Donald M Bers · Cincinnati Childrens Hosp Med Ctr$40,886,752
- Russell E Ware · Duke University$30,715,534
- David Herlie Robertson · Vanderbilt University$28,928,663
- Henry R Halperin · Johns Hopkins University$27,245,374
Research focus
ArrhythmiaMediatingFunctional DisorderPropertyOpticsHeartBaseAcuteCardiacHeart FailureProteinsOverexpressionMuscle CellsAction PotentialsReperfusion InjuryMechanicsExhibitsIn VivoOxidative StressMitochondriaMolecularChronicLinkMetabolic
Grant awards (34)
Desmoplakinopathies: Integrated Pathophysiology and Therapeutics$673,551
R01 · FY2025 · HL
Desmoplakinopathies: Integrated Pathophysiology and Therapeutics$660,080
R01 · FY2024 · HL
Metabolic signaling in atrial fibrillation and remodeling$541,072
R01 · FY2024 · HL
Desmoplakinopathies: Integrated Pathophysiology and Therapeutics$673,551
R01 · FY2023 · HL
Metabolic signaling in atrial fibrillation and remodeling$552,114
R01 · FY2023 · HL
Mitochondrial fission in diabetes-related arrhythmia$418,750
R01 · FY2023 · HL · contact PI
Optimizing AF ablation by a novel optogenetics and computational approach$209,375
R21 · FY2023 · HL · contact PI
Metabolic signaling in atrial fibrillation and remodeling$552,114
R01 · FY2022 · HL
Mitochondrial fission in diabetes-related arrhythmia$418,750
R01 · FY2022 · HL · contact PI
Optimizing AF ablation by a novel optogenetics and computational approach$251,250
R21 · FY2022 · HL · contact PI
Metabolic signaling in atrial fibrillation and remodeling$550,439
R01 · FY2021 · HL
Mitochondrial fission in diabetes-related arrhythmia$418,750
R01 · FY2021 · HL · contact PI
Molecular Determinants of Mitochondrial Instability and Arrhythmias$502,067
R01 · FY2020 · HL
Mitochondrial fission in diabetes-related arrhythmia$418,750
R01 · FY2020 · HL · contact PI
Treating Ventricle and Valve: New Synergies for Ischemic LV Remodeling with MR$691,269
R01 · FY2019 · HL
Molecular Determinants of Mitochondrial Instability and Arrhythmias$500,034
R01 · FY2019 · HL
Molecular Determinants of Mitochondrial Instability and Arrhythmias$497,882
R01 · FY2018 · HL
Targeting Abnormal Calcium Cycling Using Novel Gene Therapy Vectors$733,804
R01 · FY2017 · HL
Molecular Determinants of Mitochondrial Instability and Arrhythmias$511,486
R01 · FY2017 · HL
Role of CCN5 in heart failure related arrhythmias$211,875
R21 · FY2017 · AG · contact PI
Targeting Abnormal Calcium Cycling Using Novel Gene Therapy Vectors$733,804
R01 · FY2016 · HL
Role of STIM1 in cardiac hypertrophy and heart failure$423,750
R01 · FY2016 · HL · contact PI
Role of CCN5 in heart failure related arrhythmias$254,250
R21 · FY2016 · AG · contact PI
Targeting Abnormal Calcium Cycling Using Novel Gene Therapy Vectors$722,797
R01 · FY2015 · HL
Targeting Abnormal Calcium Cycling Using Novel Gene Therapy Vectors$733,804
R01 · FY2014 · HL
Regulating Mitochondrial Fission for Arrhythmia Prevention$286,779
R21 · FY2014 · HL · contact PI
Regulating Mitochondrial Fission for Arrhythmia Prevention$161,364
R21 · FY2013 · HL · contact PI
Mechanisms Underlying Mitrochondrial Dysfunction in the Diabetic Heart$458,405
R01 · FY2012 · HL
Integrative Investigation of Mitochondrial Dysfunction$296,625
R21 · FY2012 · HL · contact PI
Mechanisms Underlying Mitrochondrial Dysfunction in the Diabetic Heart$459,979
R01 · FY2011 · HL
Integrative Investigation of Mitochondrial Dysfunction$169,500
R21 · FY2011 · HL · contact PI
Mechanisms Underlying Mitrochondrial Dysfunction in the Diabetic Heart$32,737
R01 · FY2011 · HL
Mechanisms Underlying Mitrochondrial Dysfunction in the Diabetic Heart$463,163
R01 · FY2010 · HL
Mechanisms Underlying Mitrochondrial Dysfunction in the Diabetic Heart$530,741
R01 · FY2009 · HL